Navigation Links
Heartland Plant Innovations Wins Kansas Bioscience Authority Funding
Date:8/7/2012

MANHATTAN, Kan., Aug. 7, 2012 /PRNewswire/ -- Heartland Plant Innovations (HPI) has been awarded $2.5 million in funding from the Kansas Bioscience Authority (KBA) for the fiscal year beginning July 1, 2012.  HPI will utilize this funding to continue its mission of accelerating research, development, and commercialization of profitable innovations in the market performance of wheat and sorghum.  As with other KBA awards, funding is tied to HPI's achievement of key milestones during the months ahead. 

HPI was founded in 2009 with start-up support from the Life Science Center of Innovation Program of the KBA.

"This funding will allow HPI to continue the exciting research that we have advanced over the last 3 years.  We are confident that this work will result in commercialization of valuable new products," said Forrest Chumley, Ph.D., President and CEO of HPI.  "We are appreciative of the KBA's confidence in HPI and are confident that this investment will result in a large payback to the Kansas economy."

HPI provides customers with advanced plant breeding services and high-value genetic traits.  HPI produces, on a fee-for-service basis, wheat doubled haploid lines (DH) for breeders and geneticists.  HPI has produced and sold nearly 15,000 doubled haploids to 10 universities, 3 USDA laboratories, and 2 private companies over the last 20 months.  Upon its completion in December 2012, HPI will move into the state-of-the-art Kansas Wheat Innovation Center which will provide HPI with the capacity to produce up to 50,000 doubled haploid lines per year. This new facility will firmly position Heartland Plant Innovations as the heartland's leader in meeting global wheat needs and leverage the State of Kansas' commitment to agriculture and leadership in business.

HPI is engaged in active partnerships with academic research institutions and industry leaders in trait discovery and advancement. "I think it's
'/>"/>

SOURCE Heartland Plant Innovations
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Implanted neurons, grown in the lab, take charge of brain circuitry
2. Integrated 3-D Imaging Facilitates Human Face Transplantation
3. MU researchers identify key plant immune response in fight against bacteria
4. Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
5. Life Technologies Plant in Austin, Texas Named One of IndustryWeeks Top Ten Best Plants for 2011
6. Chimerix Antiviral Compound, CMX001, Meets CMV Phase 2 Primary Endpoint in Allogeneic Hematopoietic Stem Cell Transplant Recipients
7. First successful human results achieved: Implantable wireless microchip drug delivery device
8. Machine Preservation Significantly Improves Kidney Transplant Survival Over 3 Years Compared to Traditional box of ice
9. Gut Microbiota Transplantation may Prevent Development of Diabetes and Fatty Liver Disease
10. Butamax™ and Fagen Announce Collaboration to Retrofit Ethanol Plants for Biobutanol Production
11. New Data Shows GeNO LLC Nitric Oxide Delivery System Provided Nitric Oxide With Low Levels of Nitrogen Dioxide for Heart Transplant Patient Evaluation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... According to a new market ... Asia to Witness Highest Growth ... cell culture market was valued at US$ 586.1 Mn in ... of 29.1% to account for US$ 2,717.6 Mn by ... 3D cell culture refers to a ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... competitive market analysis and premium industry insights on the global resorcinol industry. The ... a collective study of vivid market scenarios and analysis of primary and secondary ...
(Date:7/30/2015)... AACC welcomed thousands of medical professionals ... Meeting & Clinical Lab Expo in ... showcased revolutionary advancements in clinical testing technology and ... to diagnose patients quickly and accurately and make ... As of Wednesday, July 29, more than ...
(Date:7/30/2015)... -- According to a new market research ... PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), by ... End Users - Global Forecast to 2020", published by ... 2,107.99 million by 2020 from USD 1,034.93 million in ... Browse more than 75 market ...
Breaking Biology Technology:Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 2Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 3Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 4Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4
... , , , , Guy Adami, ... , Vincent Prezioso, Eppendorf Scientific, Inc., Westbury, NY, USA , ... , , Transgenic ... into their genome. The most common method of introducing recombinant DNA , ...
... , , , , Bodo ... Borstel, Parkallee 22, , D-23845 Borstel, Germany. , ... , , Abstract ... enhancer for , improving PCR efficiency: the TaqMaster. With this ...
... , , , , Christian ... , Lars-Erik Peters, Eppendorf 5Prime, USA , ... The reliability of a PCR* experiment is dependent on its sensitivity, , ... PCR is efficient sample preparation, as well as thermal ...
Cached Biology Technology:The use of TaqMaster PCR Enhancer 2The use of TaqMaster PCR Enhancer 3The use of TaqMaster PCR Enhancer 4The use of TaqMaster PCR Enhancer 5Enhancing PCR* Efficiency with MasterTaq 2Enhancing PCR* Efficiency with MasterTaq 3Enhancing PCR* Efficiency with MasterTaq 4Enhancing PCR* Efficiency with MasterTaq 5Efficient and Reliable PCR Setup Using Eppendorf MasterMix 2Efficient and Reliable PCR Setup Using Eppendorf MasterMix 3Efficient and Reliable PCR Setup Using Eppendorf MasterMix 4Efficient and Reliable PCR Setup Using Eppendorf MasterMix 5Efficient and Reliable PCR Setup Using Eppendorf MasterMix 6Efficient and Reliable PCR Setup Using Eppendorf MasterMix 7
(Date:8/4/2015)... 2015  AMRI (NASDAQ: AMRI ) today reported financial and ... Highlights: , Second quarter contract revenue of ... , Adjusted contract margins of 26 % ... a $0.05 decrease in EPS from royalties in the current quarter ... "We are very pleased to present another strong financial ...
(Date:7/31/2015)... China , 31 de julho de 2015 /PRNewswire/ ... (ICG-10, www.icg-10.org ) será realizada pela BGI de 22-25 ... . A conferência está celebrando seu ... em 2006, a ICG se tornou uma das reuniões ... um dos encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... , Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market and ... has filed provisional patent 62/198989 for ELECTRONIC ... highlights a method to advance crypto-currencies such as Bitcoin ... a common, uniform way to manage all payments.  ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4
... Trust and the Arthritis Research Campaign has identified two ... disease primarily causing back pain and progressive stiffness. The ... a treatment currently being trialled for Crohn,s disease may ... affects as many as 1 in 200 men and ...
... with separate sexes, embryos commit to becoming male or female ... made by sex determination genes on the sex chromosomes. ... during evolution. In contrast, the sex determination genes and ... features of the genome. A research team formed ...
... partnership to build an integrated neuroscience research programme that ... Strategic research infrastructure for tertiary hospitals and medical ... late phase clinical trials in Singapore. These are ... the Biomedical Sciences International Advisory Council (BMS IAC) at ...
Cached Biology News:Major genetic breakthrough for ankylosing spondylitis brings treatment hope 2Major genetic breakthrough for ankylosing spondylitis brings treatment hope 3A new explanation for evolutionary changes in genetic sex-determination systems 2Phase 2 of Singapore's Biomedical Sciences Initiative gains momentum for clinical research 2Phase 2 of Singapore's Biomedical Sciences Initiative gains momentum for clinical research 3Phase 2 of Singapore's Biomedical Sciences Initiative gains momentum for clinical research 4Phase 2 of Singapore's Biomedical Sciences Initiative gains momentum for clinical research 5Phase 2 of Singapore's Biomedical Sciences Initiative gains momentum for clinical research 6
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
The S. cerevisiae Hansen strains are the parental yeast strains from which the deletions were derived....
Tissue culture grade....
Mus musculus MARCKS-like protein, mRNA...
Biology Products: